Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FFQGG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,441
Award facts
- Contract value 100% obligated
- $68,441.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $68,441.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for Gardasil 9 syringes (0.5 mL) on September 5, 2025, with completion targeted for September 8, 2025. This non-set-aside contract represents a pediatric and adult vaccination product delivery supporting the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA's extensive procurement network.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and the U.S. Coast Guard, positioning AmerisourceBergen as a primary pharmaceutical vendor within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FFQGG?
SPE2DB25FFQGG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FFQGG worth?
The government has obligated $68,441 on SPE2DB25FFQGG.
Is contract SPE2DB25FFQGG an order under another contract?
Yes. SPE2DB25FFQGG is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFQGG competed?
The extent of competition for SPE2DB25FFQGG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award